Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Sanofi-Synthelabo discloses synthesis and use of new alpha-azacyclomethylquinolines

Sep. 19, 2000

Preclinical results in guinea pigs suggest novel mechanism of action for TAK-637

Sep. 18, 2000

Update on U.S. status of Zonagen's sexual dysfunction products

Sep. 15, 2000

Cystistat approved for expanded indications in Europe

Sep. 14, 2000

Renal I/R injury prevented by VAS-971 therapy in canine model

Sep. 14, 2000

Arch scientists discover new peptides with mitogenic properties

Sep. 12, 2000

New polyazanaphthalenones for BPH

Sep. 8, 2000

Merck's focus on more effective and safe agents for BPH continues

Sep. 8, 2000

Ditropan XL and Detrol produce similar incidence of dry mouth

Sep. 7, 2000

Pharmacia and Recordati collaborate on potential overactive bladder treatments

Sep. 1, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 28, 2026
New schizophrenia targets challenge trial design
BioWorld
The search for better schizophrenia therapies is moving beyond dopamine toward a growing number of experimental targets. According to researchers, the repeated...
Regulatory actions for July 27, 2026
BioWorld
Regulatory snapshots for biopharma and med tech, including global submissions and approvals, and other regulatory decisions and designations: Alfasigma,...
AACR D3: ONM-421 shows antigen-independent tumor control
BioWorld Science
At the American Association for Cancer Research’s inaugural Drug Discovery and Development conference (AACR D3), Onconano Medicine Inc. presented preclinical data...